Loading...

Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202

AIDS Clinical Trial Group study A5202 (ClinicalTrials.gov identifier NCT00118898) was a phase 3b, randomized, partially blinded equivalence study of open-label atazanavir/ritonavir or efavirenz, plus either placebo-controlled tenofovir disoproxil fumarate/emtricitabine or abacavir/lamivudine, in tre...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Antimicrob Agents Chemother
Main Authors: Bednasz, Cindy J., Venuto, Charles S., Ma, Qing, Daar, Eric S., Sax, Paul E., Fischl, Margaret A., Collier, Ann C., Smith, Kimberly Y., Tierney, Camlin, Acosta, Edward P., Mager, Donald E., Morse, Gene D.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437535/
https://ncbi.nlm.nih.gov/pubmed/30642925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01638-18
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!